FOR PATIENTS WITH HEMOPHILIA B ACHIEVE
NEW HEIGHTS
with proven, long-lasting bleed protection

#1 FACTOR IX MOST PRESCRIBED FOR PROPHYLAXIS*

   ONLY IDELVION DELIVERS  

plus
plus

*Hemophilia FIX Market Assessment. Third-Party Market Research.

Once well‑controlled (1 month without spontaneous bleeding or requiring dose adjustments on a weekly dose of ≤40 IU/kg), people 12 years and older can be transitioned to 14-day dosing.

The average dose for adults and adolescents receiving prophylaxis every 7 days was 37 IU/kg.

§The median AsBR for people who started on 7- or 14-day prophylaxis was 0. For people who switched to phophylaxis from on-demand, the median AsBR was 0.7. AsBR=annualized spontaneous bleed rate.

I Choose IDELVION–Ray

Learn more about IDELVION powerful prophylaxis 

IDELVION Connect™ offers a wide variety of resources like connecting with other patients and financial support

idelvion connect logo

As a caregiver, you play a vital role in treatment, and we have information just for you

Milinda–Patient testimonial
X
You are now leaving the current website.

Do you want to continue?